Prescribing ketamine with care and context

News

The Matthew Perry Case - Prescribing Ketamine with Care and Context

published:

updated:

July 29, 2025

Since the passing of Matthew Perry, there has been a spurt in media coverage on his death, both sympathetic and sensational. Perry spent decades advocating for addiction awareness and recovery, offering a rare and vulnerable voice as a public figure. Some narratives celebrate that complexity, while others reduce his life to a cautionary tale or place blame.

It is time to move beyond the speculation and look into the bigger picture of the systems of work: why and how drugs, such as ketamine, are prescribed, how a lack of continuity surrounding mental health care may not promote recovery, and what factor is the media framing of substance use disorders and how it can contribute to the misconception and lack of understanding.   

At Isha Health, we recognize that treatment must be evidence-based and empathetic. In today's blog, we are discussing our safety-based and healing-based prescribing practices, and how respectful reporting can help build a more supportive future.

The Matthew Perry Moment: What We Talk About When We Talk About Addiction

The passing of an actor we all loved, such as Matthew Perry, hits a cultural chord. His honesty about addiction was central to his story, and it's essential to preserve that truth in how we remember his life and death.

Again and again, the headlines are scandalous or blame-oriented. This framing creates greater stigma, disregards the facts of substance use disorders as a health condition, and does not want to consider deeper issues of how we, as a society and as our healthcare systems, view a person in recovery.

Careful media reporting can both do justice to the story of an individual and also give insight into the failures of care and the promise of new medicines, such as ketamine, when used safely.

Prescribing Ketamine with Care and Context

What Type of Ketamine Are We Talking About?

At Isha Health, we prescribe racemic ketamine in the form of a compounded sublingual troche—a small tablet that dissolves under the tongue. It is composed of both R- and S-enantiomers of ketamine. It is used differently from the FDA-approved nasal spray, esketamine (Spravato), or racemic ketamine, the traditional form containing equal parts of R- and S-ketamine, administered intravenously.

At Isha Health, we are using racemic ketamine (a mixture of ketamine) as a sublingual troche that is compounded. Whereas certain clinics practice racemic ketamine through intravenous administration of infusion, our clinicians incorporate this approach into a combination with KAP (Ketamine-Assisted Psychotherapy), having undergone formal training in KAP methodology to provide a safe and efficient treatment. 

The starting point of our method is thoughtful evaluation, individualized planning, and clinical monitoring to administer medications not merely as a prescriptive aspect, but as a therapeutic tool that facilitates healing and recovery. 

Safety Begins With Structure: How iSHA Health Prescribes Ketamine

At Isha Health, ketamine treatment is never one-size-fits-all. Each prescription is based on a thorough clinical evaluation, guided by structured protocols and individualized therapeutic planning. Our team carefully assesses medical and psychological factors before recommending treatment. We combine racemic ketamine with targeted support, including integration sessions and KAP-trained guidance, to ensure every step promotes safety, clarity, and lasting healing. This personalized, step-by-step approach reflects Isha Health’s commitment to intentional, transformative care.

Clinical Evaluation

Every customer begins the process with a thorough 60-minute medical assessment conducted via video. We also evaluate the mental health history, medications, different contraindications, and personal objectives. Clinicians prescribe ketamine only when it is clinically necessary and always with informed consent. 

Dosing and Monitoring

Every session will include clear instructions on equipment preparation, what to expect, and how to handle the experience responsibly. Clinicians monitor the patient's progress through follow-up visits and assess it using validated psychological scales.

Therapeutic Integration

All clients are highly encouraged to collaborate with skilled ketamine-assisted therapists who would guide them to reflect on the findings and utilize them in their everyday lives.  

Home as a Healing Environment

The home then becomes a place of deliberate healing when clear guidelines are being followed. Patients are guided to get an environment that is free of any distractions and safety, have someone they can trust around them, music, or meditation that one can refer to during this process, and have a clinician explain what is going on before and after the sessions.

Misconceptions Around Ketamine: Language Shapes Stigma

Ketamine remains shrouded in stories among the general public. Ketamine is, quite often, referred to as a club drug or even wrongly portrayed as addictive. The clinical uses of this drug differ significantly in terms of frequency. 

 

Ketamine, with caution and support in key administration, has been shown to reduce depression, anxiety symptoms, PTSD, and suicidality. It is not, however, a miracle-cure, and neither must it be so treated.

 

Using irresponsible language in media reports, such as referring to ketamine as a "dangerous anesthetic" or making inaccurate comparisons to overdose, can discourage people from seeking help and fuel public apprehension or misunderstanding. Similarly, using stigmatizing terms like "addict," "drug abuser," or "troubled star" reinforces negative stereotypes and oversimplifies the complexity of addiction and recovery

 What Responsible Reporting Should Look Like

It is up to journalists and media houses to ensure that they present stories in an acceptable format that seeks to inform, rather than entertain. This implies no moralising tones, an emphasis on structural reasons, and the presence of specialist voices that keep things in perspective in terms of risks and benefits. 

A well-researched article could accomplish the following:

  • Explain the type of ketamine in question, and whether it was a prescription or an illegal one.
  • Point out a distinction between non-clinical and clinical use.
  • Get the views of psychiatrists, specialists in addiction medicine, and the views of the recovering addict.
  • Do not make people reductive of diagnosis or relapse.
  • Identify and point out failures in care, but do not blame people.

Beyond the Individual: Addressing Fragmented Care

Fragmentation is one of the biggest threats to safe treatment. It could be that a patient is taking ketamine with one provider, the therapist may be in a different network, and the primary care physician may be oblivious of the other. This discontinuity may add risk, especially where there is a history of substance use. 

We have taken the responsibility of filling those gaps at Isha Health through our coordinated care and integration resources. We understand that context-free, unaccompanied, and insipid medication can be harmful rather than beneficial. We also accept that the history of drug use does not exclude a person as a candidate to receive treatment. Still, it must be approached by listening more and applying specific guidelines, as well as trusting the patient.

Healing Happens in Context, Not Isolation

People do not heal in isolation. Recovering is not merely an issue of will power or compliance; it is a matter of systems, relationships, and access to caring, arranged care. We do not recognize the truth when we stigmatize things or people based on assumptions that are made about them.

Patients with unregulated prescriptions of ketamine, where no precautionary measures and training have been introduced, may be unstable. However, when applied in a thoughtfully developed, trauma-informed system, such as ours, it can be an effective re-entry system, perspective, and healing system.

The Role of the Media in Public Healing

Policy, perception, and will have their narratives in the media. As coverage focuses on humanity, complexity, and systematic accountability, a cultural shift towards a shaming-to-supportive culture occurs.

Here, it comes to actually narrating stories that:

  • Note the potential and the constraints of interventions such as ketamine.
  • Explain the distinction between a therapeutic and recreational use.
  • Radicalize those voices in long-term recovery.
  • Oppose care holes without dehumanizing people.

Matthew Perry aspired to leave a legacy of helping others. Respecting that desire implies altering the language used in treatment, recovery, and for individuals who undergo both.

Conclusion

Ketamine treatment at Isha Health is not just about a short-term solution, but it should be considered as a stage of the multi-step process of therapy. It is our position that safe prescribing, clinical monitoring, and psychotherapeutic integration are obligatory rather than optional requirements in responsible care. 

We also adhere to language power. Whether at the battlefield or through the media, words can either initiate healing or extend the damage. It behooves us, as professionals in the healthcare field and the culture, to make wise choices.  

Addiction is never unidimensional, just as healing. By embracing a space where we acknowledge complexity, place more weight on structure, and prioritize empathy over stigma, we are creating a new direction where not only science but also the soul of recovery becomes respected. 

Get the latest insights on psychedelic therapy, mental health, and innovative treatments—straight to your inbox.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Sign up
for the
Isha Health
Newsletter

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Expanding Access to Ketamine-Assisted Psychotherapy: A New Collaboration Between Alchemy and Isha Health

Psychedelic Therapy Legislation Expands Across the U.S.

FDA Expands Approval of Spravato: What This Means for Depression Treatment

DEA Extends Telemedicine Prescribing

How the Telehealth Modernization Act of 2024 Could Transform Medicare Services

The Latest From Isha Health